Ono Pharma Foundation is located in New York, NY. The organization was established in 2017. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ono Pharma Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 01/2023, Ono Pharma Foundation generated $287.1k in total revenue. This represents relatively stable growth, over the past 5 years the organization has increased revenue by an average of 7.3% each year. All expenses for the organization totaled $3.3m during the year ending 01/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2019, Ono Pharma Foundation has awarded 134 individual grants totaling $51,025,918. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2023
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE PURPOSE OF THE ONO PHARMA BREAKTHROUGH SCIENCE INITIATIVE AWARDS PROGRAM IS TO SUPPORT SCIENTIST PRINCIPAL INVESTIGATORS WITH CREATIVE IDEAS IN SELECTED SCIENTIFIC RESEARCH FIELDS WITH THE MISSION OF SEEKING DISCOVERIES/SOLUTIONS AND DEVELOPMENT OF HIGH IMPACT SCIENCE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Tetsuya Sugiyama Director | 3 | $0 | |
Hiroshi Ochiai President | 10 | $0 | |
Toru Maruyama Treasurer | 6 | $0 | |
Masaya Kokubo Secretary | 2 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $287,144 |
Interest on Savings | $0 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $287,144 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $0 |
Depreciation | $5,208 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $25,528 |
Total operating and administrative expenses | $292,955 |
Contributions, gifts, grants paid | $3,031,165 |
Total expenses and disbursements | $3,324,120 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $2,604,296 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $9,818,611 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $16,667 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $9,124 |
Total assets | $12,448,698 |
Accounts payable and accrued expenses | $0 |
Grants payable | $4,804,892 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $16,615 |
Total liabilities | $4,821,507 |
Over the last fiscal year, Ono Pharma Foundation has awarded $8,944,891 in support to 27 organizations.
Grant Recipient | Amount |
---|---|
BROAD INSTITUTE OF HARVARD & MIT DRS ERIC MINIKEL & SONIA VALLABH PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $172,500 |
UNIVERSITY OF CALIFORNIA DR R SPITALE PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $172,500 |
THE SCRIPPS RESEARCH INSTITUTE MICHAEL A ERB PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $345,000 |
BOSTON COLLEGE ERANTHIE WEERAPANA PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $345,000 |
HARVARD UNIVERSITY DR B LIAU PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $172,500 |
UNIVERSITY OF CALIFORNIA SAN FRANCISCO JASON K SELLO PURPOSE: THE ONO PHARMA BREAKTHROUGH SCIENCE INTITIATIVE AWARDS PROGRAM | $345,000 |